These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24129231)

  • 1. Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.
    Gentry-Maharaj A; Fourkala EO; Burnell M; Ryan A; Apostolidou S; Habib M; Sharma A; Parmar M; Jacobs I; Menon U
    Br J Cancer; 2013 Nov; 109(11):2875-9. PubMed ID: 24129231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.
    Fourkala EO; Gentry-Maharaj A; Burnell M; Ryan A; Manchanda R; Dawnay A; Jacobs I; Widschwendter M; Menon U
    Br J Cancer; 2012 Jun; 106(12):1910-6. PubMed ID: 22596242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
    Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
    Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Thomas DS; Gentry-Maharaj A; Ryan A; Fourkala EO; Apostolidou S; Burnell M; Alderton W; Barnes J; Timms JF; Menon U
    Cancer Epidemiol; 2019 Feb; 58():167-174. PubMed ID: 30616086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
    Johns LE; Coleman DA; Swerdlow AJ; Moss SM
    Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
    Johns LE; Swerdlow AJ; Moss SM
    J Med Screen; 2018 Jun; 25(2):76-81. PubMed ID: 28675954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence in England and Wales and New Zealand and in migrants between the two countries.
    Swerdlow AJ; Cooke KR; Skegg DC; Wilkinson J
    Br J Cancer; 1995 Jul; 72(1):236-43. PubMed ID: 7599059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability and participation in breast and bowel cancer screening in England: a large prospective study.
    Floud S; Barnes I; Verfürden M; Kuper H; Gathani T; Blanks RG; Alison R; Patnick J; Beral V; Green J; Reeves GK
    Br J Cancer; 2017 Nov; 117(11):1711-1714. PubMed ID: 28972966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
    Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
    Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease due to cancer in England and Wales.
    Jayatilleke N; Pashayan N; Powles JW
    J Public Health (Oxf); 2012 Jun; 34(2):287-95. PubMed ID: 22138490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
    Quinn M; Allen E
    BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data.
    Woods LM; Rachet B; O'Connell D; Lawrence G; Tracey E; Willmore A; Coleman MP
    Int J Cancer; 2009 May; 124(10):2391-9. PubMed ID: 19180628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
    Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
    J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales?
    Dickinson HO; Salotti JA; Birch PJ; Reid MM; Malcolm A; Parker L
    J Epidemiol Community Health; 2001 Jun; 55(6):414-22. PubMed ID: 11351000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
    Waller M; Moss S; Watson J; Møller H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2257-61. PubMed ID: 18006913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence in Murcia, Spain, in 1982: first results from a population-based cancer registry.
    Navarro C; Perez-Flores D; Coleman MP
    Int J Cancer; 1986 Jul; 38(1):1-7. PubMed ID: 3721619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completeness of case ascertainment at the Irish National Cancer Registry.
    O'Brien K; Comber H; Sharp L
    Ir J Med Sci; 2014 Jun; 183(2):219-24. PubMed ID: 23955644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study.
    Alessy SA; Davies EA; Rawlinson J; Baker M; Lüchtenborg M
    BMJ Open; 2019 Dec; 9(12):e034344. PubMed ID: 31848175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Gentry-Maharaj A; Glazer C; Burnell M; Ryan A; Berry H; Kalsi J; Woolas R; Skates SJ; Campbell S; Parmar M; Jacobs I; Menon U
    BMJ Open; 2017 Mar; 7(3):e011822. PubMed ID: 28264823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.